Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sagar Rakshit

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Journal of Thoracic Disease|December 7, 2020
Immunotherapy in patients with autoimmune diseaseSagar Rakshit, Julian R Molina
Blood Cancer Journal|September 30, 2021
Extramedullary disease in multiple myelomaRadhika Bansal, Sagar Rakshit, Shaji Kumar
Frontiers in Oncology|February 24, 2022
Correlation of Somatostatin Receptor 2 Expression, 68Ga-DOTATATE PET Scan and Octreotide Treatment in Thymic Epithelial TumorsAnja C Roden, Sagar Rakshit, Geoffrey B Johnson, et al.
The Oncologist|August 3, 2018
Premature Clinical Trial Discontinuation in the Era of Immune Checkpoint InhibitorsMonica Khunger, Sagar Rakshit, Adrian V Hernandez, et al.
Chest|May 14, 2017
Incidence of Pneumonitis With Use of Programmed Death 1 and Programmed Death-Ligand 1 Inhibitors in Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis of TrialsMonica Khunger, Sagar Rakshit, Vinay Pasupuleti, et al.
Clinical Lung Cancer|February 14, 2018
Safety and Efficacy of PD-1/PD-L1 Inhibitors in Treatment-Naive and Chemotherapy-Refractory Patients With Non-Small-Cell Lung Cancer: A Systematic Review and Meta-AnalysisMonica Khunger, Prantesh Jain, Sagar Rakshit, et al.
JCO Precision Oncology|February 17, 2022
Programmed Cell Death 1 (PD-1) Ligand (PD-L1) Expression in Solid Tumors As a Predictive Biomarker of Benefit From PD-1/PD-L1 Axis Inhibitors: A Systematic Review and Meta-AnalysisMonica Khunger, Adrian V Hernandez, Vinay Pasupuleti, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|March 4, 2020
Neutrophil to lymphocyte ratio as a prognostic marker in metastatic gallbladder cancerMohamed Mady, Kritika Prasai, Sri H Tella, et al.
Medical Physics|March 16, 2017
An integrated segmentation and shape-based classification scheme for distinguishing adenocarcinomas from granulomas on lung CTMehdi Alilou, Niha Beig, Mahdi Orooji, et al.
Scientific Reports|October 30, 2019
Author Correction: Quantitative vessel tortuosity: A potential CT imaging biomarker for distinguishing lung granulomas from adenocarcinomasMehdi Alilou, Mahdi Orooji, Niha Beig, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Journal of Thoracic Disease|December 7, 2020
Immunotherapy in patients with autoimmune diseaseSagar Rakshit, Julian R Molina
Blood Cancer Journal|September 30, 2021
Extramedullary disease in multiple myelomaRadhika Bansal, Sagar Rakshit, Shaji Kumar
Frontiers in Oncology|February 24, 2022
Correlation of Somatostatin Receptor 2 Expression, 68Ga-DOTATATE PET Scan and Octreotide Treatment in Thymic Epithelial TumorsAnja C Roden, Sagar Rakshit, Geoffrey B Johnson, et al.
The Oncologist|August 3, 2018
Premature Clinical Trial Discontinuation in the Era of Immune Checkpoint InhibitorsMonica Khunger, Sagar Rakshit, Adrian V Hernandez, et al.
Chest|May 14, 2017
Incidence of Pneumonitis With Use of Programmed Death 1 and Programmed Death-Ligand 1 Inhibitors in Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis of TrialsMonica Khunger, Sagar Rakshit, Vinay Pasupuleti, et al.
Clinical Lung Cancer|February 14, 2018
Safety and Efficacy of PD-1/PD-L1 Inhibitors in Treatment-Naive and Chemotherapy-Refractory Patients With Non-Small-Cell Lung Cancer: A Systematic Review and Meta-AnalysisMonica Khunger, Prantesh Jain, Sagar Rakshit, et al.
JCO Precision Oncology|February 17, 2022
Programmed Cell Death 1 (PD-1) Ligand (PD-L1) Expression in Solid Tumors As a Predictive Biomarker of Benefit From PD-1/PD-L1 Axis Inhibitors: A Systematic Review and Meta-AnalysisMonica Khunger, Adrian V Hernandez, Vinay Pasupuleti, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|March 4, 2020
Neutrophil to lymphocyte ratio as a prognostic marker in metastatic gallbladder cancerMohamed Mady, Kritika Prasai, Sri H Tella, et al.
Medical Physics|March 16, 2017
An integrated segmentation and shape-based classification scheme for distinguishing adenocarcinomas from granulomas on lung CTMehdi Alilou, Niha Beig, Mahdi Orooji, et al.
Scientific Reports|October 30, 2019
Author Correction: Quantitative vessel tortuosity: A potential CT imaging biomarker for distinguishing lung granulomas from adenocarcinomasMehdi Alilou, Mahdi Orooji, Niha Beig, et al.
Pageof 2